Singapore markets closed
Straits Times Index
3,264.53 -35.51 (-1.08%) S&P 500
5,187.70 +6.96 (+0.13%) Dow
38,884.26 +31.99 (+0.08%) Nasdaq
16,332.56 -16.69 (-0.10%) Bitcoin USD
62,091.32 -1,563.88 (-2.46%) CMC Crypto 200
1,288.55 -6.12 (-0.47%)
AXSM Jan 2025 70.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:57AM EDT. Market open.
| Previous close | 16.68 |
| Open | 16.68 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 70.00 |
| Expiry date | 2025-01-17 |
| Day's range | 16.68 - 16.68 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksAxsome (AXSM) Q1 Loss Widens Y/Y, Revenues Beat Estimates
Axsome's (AXSM) bottom line declines year over year in the first quarter. Strong sales of Auvelity drive revenues.
Insider MonkeyAxsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2024 Earnings Call Transcript
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2024 Earnings Call Transcript May 6, 2024 Axsome Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.44233 EPS, expectations were $-1.2. Axsome Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, […]
- GuruFocus.com
Axsome Therapeutics Inc (AXSM) (Q1 2024) Earnings Call Transcript Highlights: Soaring Revenues ...
Discover how Axsome Therapeutics achieved a 160% revenue increase and navigated heightened R&D and operational costs in Q1 2024.
© 2024 Yahoo. All rights reserved.